✦ LIBER ✦

Phase I study of cisplatin, irinotecan, and epirubicin administered every 3 weeks in patients with advanced solid tumours

✍ Scribed by Chen, X; Oza, A M; Kusenda, Z; Yi, Q-L; Kochman, D; Moore, M J; Davis, A J; Siu, L L

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I study of bendamustine hydrochl

✍ Rasschaert, M; Schrijvers, D; Van den Brande, J; Dyck, J; Bosmans, J; Merkle, K; 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 120 KB

A phase I, dose-finding study of sunitin

✍ Boven, E; Massard, C; Armand, J P; Tillier, C; Hartog, V; Brega, N M; Countourio 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 394 KB

Feasibilty study of gemcitabine and cisp

✍ Joan Carles; Cristina Suárez; Carlos Mesía; Miquel Nogué; Albert Font; Montserra 📂 Article 📅 2006 🏛 Springer Milan 🌐 Spanish ⚖ 310 KB

Randomised phase II trial of irinotecan

✍ Sekine, I; Nokihara, H; Takeda, K; Nishiwaki, Y; Nakagawa, K; Isobe, H; Mori, K; 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 108 KB

Pharmacokinetics of paclitaxel administe

✍ Vinodh R. Nannan Panday; Ronald de Wit; Jan H. Schornagel; Margaret Schot; Hilde 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 99 KB

Phase I study on docetaxel and ifosfamid

✍ Pronk, LC; Schrijvers, D; Schellens, JHM; de Bruijn, EA; Planting, ASTh; Locci-T 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 1014 KB